TDNet Discover

Background: Severe aortic stenosis (SAS) is a condition in which the aortic valve leaflets stenose and blood flow is limited through the valve. The pressure builds behind the aortic valve and this increased pressure leads to hypertension and ultimately heart failure. Heart failure significantly contributes to early mortality and decreased quality of life for patients. SAS is treated with two options: TAVR and SAVR. Purpose: This study performs an analysis of TAVR use in low-to-intermediate risk SAS patients and determines if TAVR provided better short and long-term outcomes in this patient population, based on perioperative risks and complications, than SAVR. Methods: The research was gathered through a regimented systematic review of scholarly articles across multiple databases that included data on low and intermediate risk patients with complications of TAVR and SAVR procedures. Studies were analyzed based on their level of evidence, quality, and inclusion of multiple primary and secondary outcomes. From this inquiry, 3 studies were ultimately chosen for further in-depth examination and discussion. Results: The data demonstrated no difference in all-cause mortality;however, there was a decreased incidence of new onset atrial fibrillation, myocardial infarction, acute kidney injury and stroke in low-to-intermediate risk surgical patients that underwent the TAVR procedure. Conclusion: Based on the decreased incidence of significant post-operative complications, it is recommended that patients who are low-to-intermediate risk surgical candidates be referred for TAVR instead of the SAVR procedure.